vimarsana.com

Page 38 - டஃப்ட்ஸ் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Chutes & Ladders—St Elizabeth s taps health system vet as president; Verily adds a chief revenue officer

Peter Kaprielyanhas added chief development officer of the Inspira Health Foundation to his existing responsibilities at South Jersey-based Inspira Health. The nonprofit foundation supports the provider network’s programs and care services through philanthropy. Kaprielyan has been at the health system for 20 years and was the vice president of organizational improvement and philanthropy at Underwood-Memorial Hospital, which merged with South Jersey Healthcare to form Inspira Health in 2012. He held the position of vice president of government and external relations at Inspira Health since that time and will continue in that role alongside the new title. Kaprielyan has also held positions at hospitals and medical colleges over the course of his career and serves on the boards of local government groups.

CareFirst BlueCross BlueShield welcomes accomplished physician and public health advocate as CMO

4/30/2021, 6 a.m. Dr. Tich Changamire has been ap- pointed the new Chief Medical Officer (CMO) for CareFirst BlueCross BlueShield. He will help accelerate the company’s health equity capabilities strengthening affordability, quality, and access to care. Courtesy Photo/CareFirst Baltimore— CareFirst BlueCross BlueShield (CareFirst) has appointed Dr. Tich Changamire as their new Chief Medical Officer. Dr. Changamire brings more than 20 years of medical and health plan experience, and provider-based healthcare leadership to his new role. He will lead the organization’s efforts to achieve excellence in healthcare affordability, quality, and accessibility through innovative initiatives to improve the health of members and the communities we serve.

OKYO Pharma CEO talks promising pre-clinical data for its acute and chronic ocular pain drug

OKYO Pharma CEO talks promising pre-clinical data for its acute and chronic ocular pain drug OKYO Pharma Limited s (LON:OKYO)(OTCQB:EMMLF) Dr Gary Jacob speaks to Proactive s Andrew Scott soon after announcing that a non-opioid analgesic they re developing has shown pre-clinical potential to treat acute and chronic ocular pain. OK-201 was assessed using a mouse neuropathic corneal pain model developed by Dr Pedram Hamrah, an ophthalmologist, cornea specialist, and clinician-scientist at Tufts Medical Center and professor of ophthalmology at Tufts University School of Medicine, Boston. Quick facts: Okyo Pharma Limited Price: 8 GBX

Six Princetonians to compete in Tokyo Olympics

Six Princetonians to compete in Tokyo Olympics
dailyprincetonian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyprincetonian.com Daily Mail and Mail on Sunday newspapers.

Seven Princetonians to compete in Tokyo Olympics

Seven Princetonians to compete in Tokyo Olympics
dailyprincetonian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyprincetonian.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.